NEDD4 and cancer: This finding may be attributed to the fact that NEDD4-1 negatively regulates ERα expression; consequently, low levels of NEDD4-1 lead to an upregulation of ERα, which enhances the sensitivity of cancer cells to endocrine therapy (Natori et al., 2023).